World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01473966
Date of registration: 10/11/2011
Primary sponsor: University Hospital Heidelberg
Public title: Coffee Against Obstipation in Intensive Care Treatment
Scientific title: Coffee Against Obstipation in Intensive Care Treatment
Date of first enrolment: November 2011
Target sample size: 120
Recruitment status: Enrolling by invitation
URL:  http://clinicaltrials.gov/show/NCT01473966
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention  
Countries of recruitment
Germany
Contacts
Name:   Christoph Eisenbach
Address: 
Telephone:
Email:
Affiliation:  University of Heidelberg, Heidelberg, Germany
Key inclusion & exclusion criteria

Inclusion Criteria:

- admission to the medical intensive care unit of the Dept. of Gastroenterology at the
university hospital heidelberg

- requires ventilator support for an anticipated more than 72 hours

- age older than 18 years

Exclusion Criteria:

- pregnancy

- known allergy to coffee

- mechanical ileus

- presence of enterostoma



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Obstipation
Intervention(s)
Dietary Supplement: coffee
Dietary Supplement: coffee rectally
Primary Outcome(s)
Bowel movement rate [Time Frame: participants will be followed for the duration of hospital stay, an expected average of 5 weeks]
Secondary Outcome(s)
in hospital mortality [Time Frame: participants will be followed for the duration of hospital stay, an expected average of 5 weeks]
lengths of hospitalisation [Time Frame: an average of 5 weeks of hospital stay is expected]
long term mortality [Time Frame: 6 months following discharge]
time of stay on ICU [Time Frame: participants will be followed for the duration of hospital stay, an expected average of 5 weeks]
time on mechanical ventilation [Time Frame: participants will be followed for the duration of intensive care unit stay, an expected average of 3 weeks]
Secondary ID(s)
COFFEE
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history